Standing up in public for a broader conception of value in healthcare.

65-72 of 74 News

viewpoint 8/02/16

Chandra responds to President Obama on the ACA in JAMA editorial Amitabh Chandra and co-author Jonathan Skinner respond to President Obama’s JAMA letter describing the success of the ACA READ MORE

research 7/13/16

Neumann and co-authors respond to ASCO value framework in JCO In an article published in the Journal of Clinical Oncology READ MORE

viewpoint 7/07/16

Darius Lakdawalla in the AP: A Model for More Rational Drug Prices Darius Lakdawalla is featured in The AP's Big Story READ MORE

viewpoint 6/30/16

Goldman in Modern Healthcare: Take A Lesson From Vaccines In a commentary for Modern Healthcare READ MORE

event 5/22/16

ISPOR 2016: Goldman to moderate panel on pharmaceutical pricing Dana Goldman will moderate a May 24th panel at the 21st Annual International Meeting of ISPOR titled "Pharmaceutical pricing in the United States: Are we balancing innovation and affordability?" READ MORE

event 5/20/16

ISPOR 2016: Neumann to moderate issue panel on "What's next for value frameworks?" Dr. Peter Neumann will moderate an issue panel at the ISPOR 21st Annual International Meeting this Monday, May 23rd, entitled "What's next for value frameworks for prescription drugs?" READ MORE

viewpoint 5/20/16

Chandra and Shafrin Address Value Frameworks in JAMA Amitabh Chandra, Jason Shafrin, and Ravider Dhawan examine the utility of cancer value frameworks READ MORE

research 5/12/16

Special Issue of AJMC on HCV: Access, Value, and Cost of Innovative Therapies In a special issue of The American Journal of Managed Care (AJMC) on the Hepatitis C virus, released May 2016, READ MORE